Yayınlar & Eserler

Yayın Ağı
Makaleler 23
Tümü (23)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (14)
ESCI (2)
Scopus (15)
TRDizin (2)
Diğer Yayınlar (7)

1. Examining the Effects of Tramadol, on the WADA Prohibited List, on Sports Performance WADA Yasaklılar Listesine Giren Tramadolün Spor Performansı Üzerine Etkilerinin İncelenmesi

Acar Halıcı C., HACIŞEVKİ A.
Gazi Medical Journal , cilt.36, sa.1, ss.115-123, 2025 (ESCI) identifier identifier

2. AN OVERVIEW OF THE EFFECTS OF IRISIN ON METABOLIC DISORDERS

Berberoğlu H. T., Hacışevki A.
Gazi Sağlık Bilimleri Dergisi , cilt.6, sa.2, ss.33-41, 2021 (Hakemli Dergi)

3. 1,25-Dihydroxycholecalciferol: Effects on Metabolic Syndrome and Obesity: Traditional Review

Berberoğlu H. T., Hacışevki A.
Literatür Eczacılık Bilimleri Dergisi , cilt.10, sa.2, ss.257-267, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

4. Chemical Chaperone PBA Attenuates ER Stress and Upregulates SOCS3 Expression as a Regulator of Leptin Signaling

Baba B., Caliskan M., Boyuk G., Hacışevki A.
BIOCHEMISTRY-MOSCOW , cilt.86, sa.4, ss.480-488, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

5. An Overview of Vitamins and Minerals in the Prevention of COVID-19 Infection

HACIŞEVKİ A., Baba B.
GAZI MEDICAL JOURNAL , cilt.31, ss.523-527, 2020 (ESCI) Sürdürülebilir Kalkınma identifier identifier

6. Neopterin: A possible biomarkers in gastrointestinal cancer

HACIŞEVKİ A., BABA B., aslan s., ÖZKAN Y.
Journal of Faculty of Pharmacy ankara , cilt.42, sa.2, ss.32-41, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

7. Increased kynurenine/tryptophan and neopterin levels in hemodialysis

Hacisevki A., Baba B., Sezer S., Ozkan Y.
Oxidation Communications , cilt.36, sa.1, ss.246-253, 2013 (SCI-Expanded) identifier identifier

8. Oxidative stress in patients with essential hypertension: A comparison of dippers and non-dippers

Gönenç A., Hacışevki A., Tavil Y., Cengel A., Torun M.
EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.24, sa.2, ss.139-144, 2013 (SCI-Expanded) identifier identifier identifier

9. Accumulation of an Endogenous Inhibitor of Nitric Oxide Synthesis and Oxidative DNA Damage in End-Stage Renal Disease

HACIŞEVKİ A., GÖNENÇ A., Sezer S., Karakan S., Simsek B., Torun M.
CLINICAL LABORATORY , cilt.59, ss.1353-1361, 2013 (SCI-Expanded) identifier identifier identifier

10. Evaluation of oxidative stress markers and antioxidant status in alzheimer disease vascular dementia and parkinson disease

Hacışevki A., Gönenç A., Torun F. M.
Oxidation Communications , cilt.36, sa.1, ss.235-245, 2013 (SCI-Expanded)

11. Protein carbonyl content as the most general and well-used biomarker of severe oxidative stress

Hacisevki A., Baba B., Gonenc A., Aslan S.
Oxidation Communications , cilt.35, sa.2, ss.413-422, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

12. Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer

GÖNENÇ A., HACIŞEVKİ A., Aslan S., Torun M., Simsek B.
EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.23, sa.4, ss.350-354, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

13. Effect of short-term a-tocopherol supplementation on biomarkers of oxidative stress and antioxidant defence in subjects with angina pectoris

HACIŞEVKİ A., Torun M., Cengel A.
Oxidation Communications , cilt.35, sa.1, ss.128-137, 2012 (SCI-Expanded) identifier

14. Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass

Gonenc A., Hacisevki A., Griffiths H. R., Torun M., Bakkaloglu B., Simsek B.
BIOCHEMISTRY-MOSCOW , cilt.76, sa.6, ss.677-685, 2011 (SCI-Expanded) identifier identifier identifier

15. ALTERATIONS IN FREE RADICAL PRODUCTS AND ANTIOXIDANT CAPACITY IN PATIENTS UNDERGOING CORONARY ARTERY SURGERY

GÖNENÇ A., HACIŞEVKİ A., Griffiths H. R., Torun M., Karagoz H., Simsek B.
IUBMB LIFE , cilt.61, sa.3, ss.328, 2009 (SCI-Expanded) identifier

16. An Overview of Ascorbic Acid Biochemistry

Hacışevki A.
Journal of Faculty of Pharmacy of Ankara University , cilt.38, sa.3, ss.235-257, 2009 (Hakemli Dergi)

17. The Levels of Trace Elements and Electrolytes in Serum and Cerebrospinal Fluid of Patients with Acute Stroke

Köksaldı E., Hacışevki A., Torun F. M.
Journal of Faculty of Pharmacy of Ankara University , cilt.37, sa.2, ss.111-121, 2008 (Hakemli Dergi)

18. Effect of Haemodialysis on Oxidative Stress in Patients with Chronic Renal Failure.

Hacışevki A.
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.37, sa.2, ss.91-100, 2008 (Scopus)

19. Oxidative stress is decreased in off-pump versus on-pump coronary artery surgery

Gonenc A., Hacisevki A., Bakkaloglu B., Soyagir A., Torun M., Karagoz H., et al.
JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY , cilt.39, sa.4, ss.377-382, 2006 (SCI-Expanded) Creative Commons License identifier identifier identifier

20. An Evaluation of Serum Retinol and Carotene Levels and the Risk of Breast Cancer

HACIŞEVKİ A., ÖZKAN Y., GÖNENÇ A., Şimşek B., TORUN F. M.
Journal of Faculty of Pharmacy of Gazi University , cilt.20, sa.2, ss.87-94, 2003 (Hakemli Dergi) Sürdürülebilir Kalkınma

21. Ascorbic acid and alpha tocopherol levels in breast cancer patients

HACIŞEVKİ A., ÖZKAN Y., Şimşek B., TORUN F. M.
Journal of faculty of Pharmacy of Gazi University , cilt.19, sa.2, ss.113-119, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

22. Ascorbic Acid and Tocopherol Levels in Breast Cancer Patients

HACIŞEVKİ A., ÖZKAN Y., Şimşek B., TORUN F. M.
Journal of Faculty of Pharmacy of Gazi University , cilt.19, sa.2, ss.113-119, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

23. Ascorbic acid and uric acid levels in lung cancer patients

Bozkir A., Simsek B., Gungor A., Torun M.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.24, sa.1, ss.43-47, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. EVALUATION THE EFFECTS OF PHENYLBUTYRIC ACID ON OBESITY INDUCED HYPOTHALAMIC VASCULAR INTEGRITY CHANGES

Hacışevki A., Teker H. T., Baba B., Yanık T., Torun M.
3rd International Gazi Pharma Symposium Series (GPSS 2021), 8 - 10 Eylül 2021, ss.45, (Özet Bildiri) Sürdürülebilir Kalkınma

2. CURCUMIN AND VITAMIN D: EFFECTS ON OXIDATIVE DAMAGE

Tetik D., Baba B., İşgören A., Hacışevki A.
4TH HEALTH SCIENCES AND INNOVATION CONGRESS, 5 - 06 Temmuz 2021, ss.1, (Özet Bildiri)

3. ”Evaluation of serum FGF-23, vitamin K and plasma TMAO levels in patients with renal transplantation”

RUMANLI Z., BABA B., HACIŞEVKİ A.
EurasianSciEnTech 2020, 7 - 09 Ekim 2020

4. "Evaluation of serum FGF-23, vitamin K and TMAO levels in patients with renal transplantation"

Rumanlı Z., Baba B., Gök Oğuz E., Öztürk G., Öztekin S., Aylı M. D., et al.
"International Eurasian Conference on Science, Engineering and Technology" (EurasianSciEnTech 2020), Gaziantep, Türkiye, 7 - 09 Ekim 2020, ss.365, (Özet Bildiri)

5. Renal Transplant Hastalarında Üremik Toksinindoksil Sülfat ve İnflamatuvar Biyobelirteç S100B Düzeylerinin Değerlendirilmesi

RUMANLI Z., BABA B., GÖK OĞUZ E., ÖZTÜRK G., ÖZTEKİN S., AYLI M. D., et al.
V. International Congress on Natural and Health Sciences (ICNHS-2019), Türkiye, 13 - 15 Aralık 2019, (Özet Bildiri)

6. Evaluation of uremic toxin indoxyl sulfate and inflammatory biomarker S100B levels in renal transplant patients.

HACIŞEVKİ A., BABA B.
V. International Congress on Natural and Health Sciences (ICNHS-2019), 13 - 15 Aralık 2019

7. Effect of phenylbutyric acid on obesity induced hypothalamic vasculopathy

HACIŞEVKİ A., BABA B., TORUN F. M.
Balkan Clinical Laboratory Federation Meeting (BCLF 2019), 27 - 31 Ekim 2019 Sürdürülebilir Kalkınma

8. Roles of the lipid peroxidation by-product 4-hydroxynonenal and reductive power in metabolic syndrome

KAYA T., BABA B., BERBEROĞLU H. T., ÖZTÜRK B., KIRAÇ C. O., HACIŞEVKİ A.
3th International Conference on Agriculture, Food, Veterinary and Pharmacy Sciences, 16 - 18 Nisan 2019

9. Roles Of The Lipid Peroxidation By-Product 4-Hydroxynonenal And Reductive Power In Metabolic Syndrome

KAYA T., BABA B., BERBEROĞLU H. T., ÖZTÜRK B., KIRAÇ C. O., HACIŞEVKİ A.
ICAFOP 2019, Trabzon, Türkiye, 16 - 18 Nisan 2019, (Özet Bildiri)

10. HYPERFERRITINEMIA AND INFLAMMATION IN METABOLIC SYNDROME PATIENTS DIAGNOSED WITH OR WITHOUT DIABETES

AÇA H. T., BABA B., KIRAÇ C. O., ÖZTÜRK B., HACIŞEVKİ A.
12th International Symposium on Pharmaceutical Sciences (ISOPS-12) Ankara-Turkey, 26 - 29 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

11. PHENYLBUTYRC ACD MAY BEPHARMACOLOGCAL AGENT TO OBESTYASSOCIATED lNFLAMMATION

HACIŞEVKİ A., BABA B.
12th ISOPS, 26 - 29 Haziran 2018, (Özet Bildiri)

12. Possible Association of Serum Inflammatory Cytokines and Ferritin Levels with Metabolic Syndrome

AÇA H. T., BABA B., KIRAÇ C. O., ÖZTÜRK B., HACIŞEVKİ A.
EurasianBioChem 2018, 26 - 27 Nisan 2018, (Özet Bildiri)

13. ”Enhanced unfolded protein response signalling in obesity”

Baba B., Çalışkan M., Böyük G., HACIŞEVKİ A.
2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017, (Özet Bildiri)

14. ”Can ER stress be a potential regulator of resistin and caspase 3 levels in obesity”

Baba B., Çalışkan M., Böyük G., HACIŞEVKİ A.
2 nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017, (Özet Bildiri)

15. ”Changes of serum omentin and obestatin levels in patients receiving peritoneal dialysis”

Şentürk B., Baba B., BALİ M., HACIŞEVKİ A.
2nd International Gazi Pharma Symposium, 11 - 13 Ekim 2017, (Özet Bildiri)

16. ”Myeloperoxidase and Total Thiol: The Potential Roles and Their Alteration in End Stage Renal Disease”

Şentürk B., Baba B., Öneç K., BALİ M., HACIŞEVKİ A.
”Innovation in Medicine Summit-III”, 11 - 13 Mayıs 2017, (Özet Bildiri)

17. Neopterin:maligmitelerde prognostik bir belirteç

HACIŞEVKİ A., Baba B., Aslan S., ÖZKAN Y.
TBD Biyokimya Günleri, Türkiye, 2 - 05 Kasım 2016, cilt.40, (Özet Bildiri)

18. LEPTIN SIGNALING AND THE REDUCTION OF ER STRESS IN ISLETS

Baba B., Çalışkan M., Böyük G., HACIŞEVKİ A.
EMBO Conference: From Functional Genomics to Systems Biology, 12 - 15 Kasım 2016, (Özet Bildiri)

19. Neopterin: A Prognostic marker in human malignancies

HACIŞEVKİ A., BABA B., ASLAN S., ÖZKAN Y.
TBD, Biyokimya Günleri, Türkiye, 2 - 05 Kasım 2016

20. RESTORING ENDOPLASMIC RETICULUM FUNCTION BY CHEMICAL CHAPERON PBA IN OBESITY

Baba B., Çalışkan M., Böyük G., HACIŞEVKİ A.
Embo conference:Structure and function of the endoplasmik reticulum, 23 - 28 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

21. Predictive and metabolic biomarkers in prodiabetics possible association with vascular damage

Baba B., Hüseyin K., Osman G G., HACIŞEVKİ A.
GPSS- International Gazi Pharma Symposium, 12 - 15 Kasım 2015, (Özet Bildiri)

22. Oxidative modifications in patients with replacement therapies

Baba B., Tokar C. M., Kürşat Ö., BALİ M., HACIŞEVKİ A.
ISOPS-11th International Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015, (Özet Bildiri)
Kitaplar 4

1. miRNA29 AİLESİ: DİYABETİK NEFROPATİDEKİ ROLLERİ

Kalaçay D., Hacışevki A.
Güncel Biyokimya Çalışmaları III, Doğan Yücel, Editör, Akademisyen Kitabevi, Ankara, ss.75-94, 2022

2. Melatonin: Nörodejeneratif Metabolik Bozukluklar ve Kanser Üzerindeki Potansiyel Etkileri

Baba B., Hacışevki A.
Güncel Biyokimya Çalışmaları II, Doğan Yücel, Editör, Akademisyen Kitabevi, Ankara, ss.15-30, 2021

3. Activation of inflammatory signalling pathways in metabolic syndrome: Changes in adipokines and cytokines

Hacışevki A., Berberoğlu H. T.
Current Biochemical Studies, Doğan Yücel, Editör, Akademisyen Kitabevi, Ankara, ss.15-36, 2020

4. An Overview of Melatonin as an Antioxidant Molecule:A Biochemical Approach

Hacışevki A., Baba B.
Melatonin Molecular Biology, Clinical and Pharmaceutical Approaches, Cristina Manuela Dragoi, Editör, Intechopen, London, ss.59-79, 2018
Metrikler

Yayın

61

Yayın (WoS)

14

Yayın (Scopus)

15

Atıf (WoS)

209

H-İndeks (WoS)

7

Atıf (Scopus)

143

H-İndeks (Scopus)

6

Atıf (Scholar)

616

H-İndeks (Scholar)

9

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

34

Proje

15

Tez Danışmanlığı

10

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları